Anzahl der Publikationen: 26
Zeitschriftenartikel
Käsmann, Lukas; Eze, Chukwuka; Taugner, Julian; Nieto, Alexander; Hofstetter, Kerstin; Kröninger, Sophie; Guggenberger, Julian; Kenndoff, Saskia; Flörsch, Benedikt; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus
ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2023):
Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 10: S. 7393-7403
[PDF, 1MB]
Holzgreve, Adrien
ORCID: https://orcid.org/0000-0002-9566-8438; Taugner, Julian; Käsmann, Lukas; Müller, Philipp; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Winkelmann, Michael; Unterrainer, Lena M.; Nieto, Alexander E.; Bartenstein, Peter; Kunz, Wolfgang G.
ORCID: https://orcid.org/0000-0002-5021-1952; Ricke, Jens; Belka, Claus
ORCID: https://orcid.org/0000-0002-1287-7825; Eze, Chukwuka
ORCID: https://orcid.org/0000-0003-3779-1398; Unterrainer, Marcus und Manapov, Farkhad
(2023):
Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 50, Nr. 8: S. 2466-2476
[PDF, 1MB]
Hofstetter, Kerstin; Taugner, Julian
ORCID: https://orcid.org/0000-0003-1473-1202; Käsmann, Lukas; Mansoorian, Sina; Flörsch, Benedikt; Eze, Chukwuka; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus
ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2023):
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis.
In: Strahlentherapie und Onkologie [Forthcoming]
[PDF, 465kB]
Koehler, Viktoria Florentine; Achterfeld, Josefine; Sandner, Natalie; Koch, Christine; Wiegmann, Jonas Paul; Ivanyi, Philipp; Käsmann, Lukas; Pusch, Renate; Wolf, Dominik; Chirica, Mihaela; Knösel, Thomas; Demes, Melanie-Christin; Kumbrink, Joerg; Vogl, Thomas J.; Meyer, Gesine; Spitzweg, Christine; Bojunga, Joerg und Kroiss, Matthias
(2023):
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 15: S. 14035-14043
[PDF, 1MB]
Guggenberger, J.; Kenndoff, S.; Taugner, J.; Käsmann, Lukas; Flörsch, B.; Belka, C.; Eze, C. und Manapov, F.
(24. März 2022):
Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab.
In: BMC Cancer, Bd. 22
[PDF, 1MB]
Flörsch, Benedikt; Taugner, Julian; Käsmann, Lukas; Kenndoff, Saskia; Guggenberger, Julian; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad
(2022):
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy +/- immune checkpoint inhibition: a decade-long single-center historical analysis.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 7: S. 3267-3276
[PDF, 1MB]
Hübner, Jutta; Welter, Saskia; Ciarlo, Gianluca; Käsmann, Lukas; Ahmadi, Emadaldin und Keinki, Christian
(2022):
Patient activation, self-efficacy and usage of complementary and alternative medicine in cancer patients.
In: Medical Oncology, Bd. 39, Nr. 12, 192
Käsmann, Lukas; Taugner, Julian; Eze, Chukwuka; Nieto, Alexander; Pelikan, Carolyn; Flörsch, Benedikt; Kenndoff, Saskia; Hofer, Thomas P.; Nössner, Elfriede; Schulz, Christian; Unterrainer, Marcus; Tufman, Amanda; Klauschen, Frederick; Jung, Andreas; Neumann, Jens; Kumbrink, Jorg; Reinmuth, Niels; Bartenstein, Peter; Belka, Claus und Manapov, Farkhad
(2022):
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study.
In: Translational Lung Cancer Research, Bd. 11, Nr. 7: S. 1503-1509
[PDF, 294kB]
Oliinyk, Dmytro; Augustin, Teresa; Rauch, Josefine; Koehler, Viktoria Florentine; Belka, Claus; Spitzweg, Christine und Käsmann, Lukas
(2022):
Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 7: S. 3527-3547
[PDF, 1MB]
Eze, Chukwuka
ORCID: https://orcid.org/0000-0003-3779-1398; Guggenberger, Julian Elias; Schmidt-Hegemann, Nina-Sophie; Kenndoff, Saskia; Taugner, Julian; Käsmann, Lukas; Schönecker, Stephan; Floersch, Benedikt; Li, Minglun; Belka, Claus und Manapov, Farkhad
(2022):
Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve.
In: Cancer, Bd. 128, Nr. 12: S. 2358-2366
[PDF, 220kB]
Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2022):
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
In: Investigational new drugs, Bd. 40: S. 163-171
[PDF, 1MB]
Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2021):
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
In: Investigational New Drugs, Bd. 40, Nr. 1: S. 163-171
Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2021):
Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting.
In: Cancers, Bd. 13, Nr. 7, 1613
Schiopu, Sanziana R. I.; Käsmann, Lukas; Schönermarck, Ulf; Fischereder, Michael; Grabmaier, Ulrich; Manapov, Farkhad; Rauch, Josefine und Orban, Martin
(2021):
Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy-case report.
In: Translational Lung Cancer Research, Bd. 10, Nr. 2:
1039-
Unterrainer, Marcus; Taugner, Julian; Käsmann, Lukas; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Mittlmeier, Lena M.; Bartenstein, Peter; Kunz, Wolfgang G.; Ricke, Jens; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad
(2021):
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition.
In: European journal of nuclear medicine and molecular imaging
[PDF, 848kB]
Eze, Chukwuka; Schmidt-Hegemann, Nina-Sophie; Sawicki, Lino Morris; Kirchner, Julian; Roengvoraphoj, Olarn; Käsmann, Lukas; Mittlmeier, Lena M.; Kunz, Wolfgang G.; Tufman, Amanda; Dinkel, Julien; Ricke, Jens; Belka, Claus
ORCID: https://orcid.org/0000-0002-1287-7825; Manapov, Farkhad und Unterrainer, Marcus
(2021):
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
In: European journal of nuclear medicine and molecular imaging
[PDF, 3MB]
Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Rühle, Alexander; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus
ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2021):
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients.
In: Investigational new drugs, Bd. 39: S. 1189-1196
[PDF, 586kB]
Käsmann, Lukas; Schröder, Annemarie; Frey, Benjamin; Fleischmann, Daniel F.; Gauer, Tobias; Ebert, Nadja; Hecht, Markus; Krug, David; Niyazi, Maximilian und Mäurer, Matthias
(2020):
Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group.
In: Strahlentherapie und Onkologie
[PDF, 395kB]
Manapov, Farkhad; Käsmann, Lukas; Roengvoraphoj, Olarn; Dantes, Maurice; Schmidt-Hegemann, Nina-Sophie; Belka, Claus und Eze, Chukwuka
(2018):
Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes.
In: Lung Cancer-Targets and Therapy, Bd. 9: S. 49-55
[PDF, 163kB]
Diese Liste wurde am
Sat Feb 15 20:37:16 2025 CET
erstellt.